Latest Vaishali Pharma stock price
Vaishali Pharma P/E Ratio
VAISHALI • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
113.17
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
113.17
Current Price
₹6.79
EPS (TTM)
₹0.06
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.09
Sector Median
27.37
Sector Rank
#11 of 140
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹0.19
Sept 2025
₹0.09
Jun 2025
₹0.10
Key P/E Ratio Insights for Vaishali Pharma
- Stock appears overvalued with PE of 113.17, suggesting caution for new investments
- Trading at premium to sector average PE of 48.09
View the VAISHALI equity price for detailed stock performance.
Related Pages for Vaishali Pharma
Additional stock information and data for VAISHALI
Sector P/E Ratio Comparison
Comparing Vaishali Pharma with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |